Expert Opinion on Biological Therapy, Volume 20, Issue 9 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 20, Issue 9 (2020)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Volume 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Expanding use of CD33-directed immunotherapy
Roland B. Walter
Pages: 955-958
Published online: 02 Jul 2020
First Page PreviewforExpanding use of CD33-directed immunotherapy | Full Text | References | PDF (184.8 KB) | EPUB
  • 2112 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Editorial
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management
Marco Russano, Fabrizio Citarella, Andrea Napolitano, Emanuela Dell’Aquila, Alessio Cortellini, Francesco Pantano, Bruno Vincenzi, Giuseppe Tonini & Daniele Santini
Pages: 959-964
Published online: 02 Jul 2020
AbstractforCOVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management | Full Text | References | PDF (204.5 KB) | EPUB
  • 3479 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Editorial
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer
Daniel Larcombe-Young, Sophie Papa & John Maher
Pages: 965-970
Published online: 28 Jun 2020
First Page PreviewforPanErbB-targeted CAR T-cell immunotherapy of head and neck cancer | Full Text | References | PDF (587.1 KB) | EPUB
  • 2753 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Article
An evaluation of avelumab for the treatment of genitourinary tumors
Viktoria Stühler, Jan Moritz Maas, Simon Walz, Arnulf Stenzl & Jens Bedke
Pages: 971-979
Published online: 03 Jun 2020
AbstractforAn evaluation of avelumab for the treatment of genitourinary tumors | Full Text | References | PDF (888.6 KB) | EPUB
  • 284 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Atezolizumab in the treatment of metastatic triple-negative breast cancer
José Pérez-García, Jesús Soberino, Fabricio Racca, María Gion, Agostina Stradella & Javier Cortés
Pages: 981-989
Published online: 25 May 2020
AbstractforAtezolizumab in the treatment of metastatic triple-negative breast cancer | Full Text | References | PDF (895.4 KB) | EPUB
  • 1019 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Eculizumab for the treatment of myasthenia gravis
Renato Mantegazza & Paola Cavalcante
Pages: 991-998
Published online: 30 Jun 2020
AbstractforEculizumab for the treatment of myasthenia gravis | Full Text | References | PDF (702.3 KB) | EPUB | Supplemental
  • 622 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Abicipar pegol for neovascular age-related macular degeneration
Rehan M. Hussain, Christina Y. Weng, Charles C. Wykoff, Raya A. Gandhi & Seenu M. Hariprasad
Pages: 999-1008
Published online: 03 Jul 2020
AbstractforAbicipar pegol for neovascular age-related macular degeneration | Full Text | References | PDF (808.7 KB) | EPUB
  • 282 Views
  • 21 CrossRef citations
  • 0Altmetric

Review

Biologic therapy for advanced breast cancer: recent advances and future directions
Paolo Tarantino, Stefania Morganti & Giuseppe Curigliano
Pages: 1009-1024
Published online: 21 Apr 2020
AbstractforBiologic therapy for advanced breast cancer: recent advances and future directions | Full Text | References | PDF (1.4 MB) | EPUB
  • 773 Views
  • 22 CrossRef citations
  • 0Altmetric
Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications
Subramanian Loganathan, Sandeep N. Athalye & Shashank R. Joshi
Pages: 1025-1031
Published online: 29 Jul 2020
AbstractforItolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications | Full Text | References | PDF (2.4 MB) | EPUB
  • 10032 Views
  • 21 CrossRef citations
  • 0Altmetric
Open Access
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
Khan Sharun, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Senthilkumar Natesan, Jaideep Dhama, Yashpal S. Malik, Harapan Harapan, Raj Kumar Singh & Kuldeep Dhama
Pages: 1033-1046
Published online: 03 Aug 2020
AbstractforAntibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects | Full Text | References | PDF (1.5 MB) | EPUB
  • 2639 Views
  • 63 CrossRef citations
  • 0Altmetric
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
Giovanni Vitale, Giuseppe Lamberti, Francesca Comito, Vincenzo Di Nunno, Francesco Massari, Maria Cristina Morelli, Andrea Ardizzoni & Francesco Gelsomino
Pages: 1047-1059
Published online: 19 May 2020
AbstractforAnti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience | Full Text | References | PDF (1.4 MB) | EPUB
  • 580 Views
  • 5 CrossRef citations
  • 0Altmetric
Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders
Ankelien Duchow, Friedemann Paul & Judith Bellmann-Strobl
Pages: 1061-1072
Published online: 13 Apr 2020
AbstractforCurrent and emerging biologics for the treatment of neuromyelitis optica spectrum disorders | Full Text | References | PDF (917 KB) | EPUB
  • 576 Views
  • 14 CrossRef citations
  • 0Altmetric
Up-to-date role of biologics in the management of respiratory syncytial virus
Seyhan Boyoglu-Barnum & Ralph A. Tripp
Pages: 1073-1082
Published online: 17 Apr 2020
AbstractforUp-to-date role of biologics in the management of respiratory syncytial virus | Full Text | References | PDF (897.8 KB) | EPUB
  • 306 Views
  • 9 CrossRef citations
  • 0Altmetric
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity
Adrian Pelin, Stephen Boulton, Levi A. Tamming, John C. Bell & Ragunath Singaravelu
Pages: 1083-1097
Published online: 06 May 2020
AbstractforEngineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity | Full Text | References | PDF (1.8 MB) | EPUB
  • 693 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Research

Article
A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia
Pietro Gentile, Laura Dionisi, Jacopo Pizzicannella, Barbara de Angelis, Domenico de Fazio & Simone Garcovich
Pages: 1099-1109
Published online: 27 Jul 2020
AbstractforA randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia | Full Text | References | PDF (1.9 MB) | EPUB
  • 382 Views
  • 28 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis
Aliki I. Venetsanopoulou et al.
Review Article | Published online: 25 Jul 2024
The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review
Mohammad Shehab et al.
Review Article | Published online: 24 Jul 2024
The nail in psoriatic arthritis: new insights into prognosis and treatment
Rubén Queiro et al.
Editorial | Published online: 25 Jul 2024
Free Access
Long-acting delivery and therapies for neovascular age-related macular degeneration
Lucas W. Rowe et al.
Review Article | Published online: 22 Jul 2024
View all latest articles